<?xml version="1.0" encoding="UTF-8"?>
<p id="JVEv5-para-0131">Both HIV-1 and HBV infections are characterised by immune dysregulation and, because of their shared routes of transmission, approximately 10% of HIV-1 positive patients worldwide are thought to be co-infected with both viruses 
 <xref rid="JVEv5-bib-0042" ref-type="bibr">[42]</xref>. Immunotherapy involving vaccines as well as antibody-based approaches is an avenue being actively investigated in the field of HIV-1 and HBV cure research.
</p>
